The oncology drug success rate is improving
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
Research Directory
After probing the unknown, BerGenBio finds a gem
Interviewee/ContributorRichard GodfreyOrganisationBerGenBio ASAEuropean biotechs pause during Q3
Interviewee/ContributorWilliam EllingtonOrganisationMedNousHow basket trials are changing cancer research
Interviewee/ContributorShiva MemariOrganisationVertical KnowingBattle looms over immunotherapy combination
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare FundAltheia Science Srl: Italian biotech raises $11 mln for autoimmunity
Interviewee/ContributorMedNous financing articleOrganisationAltheia Science SrlWill CRISPR be safe enough for the clinic?
Interviewee/ContributorJonathan MooreTargeting the genetic background of cancers
Interviewee/ContributorNiall Martin and Jonathan TobinOrganisationArtios Pharma LtdA small molecule approach to regenerative medicine
Interviewee/ContributorAngela Russell and Michael SteinOrganisationOxStem LtdA new technology for targeting proteins inside cells
Interviewee/ContributorMark VaeckOrganisationComplix NV